For five decades, PHI has served as the fiscal agent for the innovative projects it supports and the dynamic public health leaders it attracts. PHI remains committed to financial integrity, transparency, and stability, and to leveraging resources, partnerships and collaboration to maximize advances that improve public health and well-being in the U.S. and around the world.
2018 Financial Snapshot
|Grants and contracts||112,206,006|
|Research and Programs services||96,421,631|
|Management and general||15,592,750|
|Net assets at beginning of year||138,379,893|
|Change in net assets||476,541|
|Net assets at end of year||18,856,434|
The information presented here is drawn from PHI’s financial statements, prepared by independent auditors Crowe LLP, Certified Public Accountants.
Financial Statements and Reviews
PHI Financial Facts
- PHI has steadily increased its annual revenue over the past 50 years
- PHI has over 700 employees
- PHI employs over 100 Principal Investigators and Program Directors
- PHI provides fiscal administration or support to over 200 public health programs
- PHI includes support for program development for Principal Investigators and Program Directors in its IDC
- PHI receives revenue from over 185 different funding sources (including government, foundations, private donors)
- PHI financial stability contributes to its being selected as one of the top 50 nonprofits to work for in 2010, 2014 and 2019
PHI Impact—Leveraging Resources to Make a Difference
- 92% more low income Californians now get their “five a day” servings of fruits and vegetables, thanks in part to a campaign over the past decade led by the Network for a Healthy California, a partnership between PHI and CDPH.
- Since 2004, dynamic young leaders in Guatemala, Honduras, Mexico and Belize have built the skills and gained experience to address youth sexual and reproductive health issues in their communities, through PHI's GOJoven sexual and reproductive health fellowship program.
- Over 90% of older adults take one or more medications regularly, and 40% are on five or more drugs. Mistakes in taking these medications decrease drug effectiveness and increase costs by hundreds of billions of dollars a year. PHI's Technologies for Medication Optimization project is testing how technology can help older patients take the right medications at the right time.
- Methamphetamine is a powerful, highly addictive stimulant that can cause problems ranging from heart disease to psychosis to domestic violence. Use is reaching epidemic proportions in certain parts of the U.S., and costs society more than $20 billion every year. PHI's Alcohol Research Group is testing a new approach to treatment, building on methods used successfully to treat alcohol addiction.